Stay updated on SG vs Docetaxel in NSCLC Clinical Trial
Sign up to get notified when there's something new on the SG vs Docetaxel in NSCLC Clinical Trial page.

Latest updates to the SG vs Docetaxel in NSCLC Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.6%
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference0.6%
- Check42 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.0%
- Check57 days agoChange DetectedThe latest updates include the posting of results on January 14, 2025, with detailed definitions and assessments for Overall Survival (OS), Progression-free Survival (PFS), Objective Response Rate (ORR), Duration of Response (DOR), Disease Control Rate (DCR), and Treatment Emergent Adverse Events (TEAEs), while previous entries related to these metrics have been removed.SummaryDifference23%
- Check64 days agoChange DetectedThe website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.SummaryDifference0.1%
- Check93 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.0%
Stay in the know with updates to SG vs Docetaxel in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SG vs Docetaxel in NSCLC Clinical Trial page.